All these are Pharma sector companies. Company F consistently reports -ve cash flows. It's stock price never compounded. All other examples reported multi-years of +ve cash flow generation. These stocks have been multi-baggers over the years.

Focus on Cash Flows vs News Flows.

A good read on Monoclonal antibodies (mAbs) and their potential. @unseenvalue @punitbansal14 Would you like to add something on the future of mAbs in pharma industry.

I stumble upon this must-watch gem - a very well reserched webinar by Abhishek Singhal to deep dive on Indian Pharma companies - https://t.co/jMa19Twpt8

@varinder_bansal, well done keep rolling out more webinars to educate retail investors. 👏👏👏